Publications by authors named "Wendy A Cooper"

67Publications

Adequate tumour cellularity is essential for accurate PD-L1 immunohistochemistry assessment on cytology cell-block specimens.

Cytopathology 2020 03 11;31(2):90-95. Epub 2020 Jan 11.

Department of Pathology at Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cyt.12795DOI Listing
March 2020

High BIN1 expression has a favorable prognosis in malignant pleural mesothelioma and is associated with tumor infiltrating lymphocytes.

Lung Cancer 2019 04 7;130:35-41. Epub 2019 Feb 7.

Sydney Medical School, The University of Sydney, Australia; Asbestos Diseases Research Institute, Sydney, NSW, Australia; Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01695002193031
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2019.02.005DOI Listing
April 2019

gene: its function and dysregulation in cancer.

J Clin Pathol 2019 Apr 29;72(4):281-284. Epub 2019 Jan 29.

Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia.

View Article

Download full-text PDF

Source
http://jcp.bmj.com/lookup/doi/10.1136/jclinpath-2018-205653
Publisher Site
http://dx.doi.org/10.1136/jclinpath-2018-205653DOI Listing
April 2019

Clinical Utility of In Situ Hybridization Assays in Head and Neck Neoplasms.

Head Neck Pathol 2019 Sep 22;13(3):397-414. Epub 2018 Nov 22.

Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12105-018-0988-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684702PMC
September 2019

Response to Editorial: The PD-L1 Immunohistochemistry Biomarker: Two Steps Forward, One Step Back?

J Thorac Oncol 2018 09;13(9):e185-e186

Department of Pathology, Peter MacCallum Cancer Center, Melbourne, Australia; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864183059
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2018.04.029DOI Listing
September 2018

Targeted Molecular Treatments in Non-Small Cell Lung Cancer: A Clinical Guide for Oncologists.

J Clin Med 2018 Jul 31;7(8). Epub 2018 Jul 31.

Chris O'Brien Lifehouse, 119-143 Missenden Road Camperdown, Camperdown, NSW 2050, Australia.

View Article

Download full-text PDF

Source
http://www.mdpi.com/2077-0383/7/8/192
Publisher Site
http://dx.doi.org/10.3390/jcm7080192DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111731PMC
July 2018

An Update on Predictive Biomarkers for Treatment Selection in Non-Small Cell Lung Cancer.

J Clin Med 2018 Jun 15;7(6). Epub 2018 Jun 15.

Sydney Medical School, The University of Sydney, Sydney 2006, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm7060153DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025105PMC
June 2018

Immunotherapy in Non-Small Cell Lung Cancer: Shifting Prognostic Paradigms.

J Clin Med 2018 Jun 14;7(6). Epub 2018 Jun 14.

Sydney Medical School, The University of Sydney, Camperdown, NSW 2006, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm7060151DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024943PMC
June 2018

Biomarkers for ALK and ROS1 in Lung Cancer: Immunohistochemistry and Fluorescent In Situ Hybridization.

Arch Pathol Lab Med 2018 08 14;142(8):922-928. Epub 2018 Jun 14.

From the Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia (Drs Luk, Selinger, Mahar, and Cooper); Central Clinical School, University of Sydney, Sydney, Australia (Dr Cooper); and the School of Medicine, Western Sydney University, Sydney, Australia (Dr Cooper).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0502-RADOI Listing
August 2018

Fluorescent In Situ Hybridization in Surgical Pathology Practice.

Adv Anat Pathol 2018 Jul;25(4):223-237

Royal Prince Alfred Hospital, Sydney Medical School, University of Sydney.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAP.0000000000000194DOI Listing
July 2018

Pigmented Paget's disease of the nipple mistaken for melanoma in situ: a diagnostic pitfall for the unwary.

Pathology 2018 Apr 1;50(3):364-367. Epub 2018 Mar 1.

Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pathol.2017.09.018DOI Listing
April 2018

Comparison of Four PD-L1 Immunohistochemical Assays in Lung Cancer.

J Thorac Oncol 2018 03 23;13(3):367-376. Epub 2017 Nov 23.

Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864173305
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2017.11.112DOI Listing
March 2018

Spindle cell variant of diffuse large B cell lymphoma occurring in the breast.

Pathology 2017 Dec 24;49(7):784-786. Epub 2017 Oct 24.

Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Australia; Sydney Medical School, University of Sydney, Australia; School of Medicine, Western Sydney University, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pathol.2017.06.009DOI Listing
December 2017

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma.

J Thorac Oncol 2017 09 16;12(9):1421-1433. Epub 2017 Jun 16.

Asbestos Diseases Research Institute, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.05.024DOI Listing
September 2017

EGFR-Co-Mutated Advanced NSCLC and Response to EGFR Tyrosine Kinase Inhibitors.

J Thorac Oncol 2017 03 14;12(3):585-590. Epub 2016 Sep 14.

Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.09.001DOI Listing
March 2017

Clinical impact of the interstitial lung disease multidisciplinary service.

Respirology 2016 11 18;21(8):1438-1444. Epub 2016 Jul 18.

Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/resp.12850DOI Listing
November 2016

The molecular profile of metastatic melanoma in Australia.

Pathology 2016 Feb 18;48(2):188-93. Epub 2016 Jan 18.

Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pathol.2015.12.008DOI Listing
February 2016

The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung Cancer.

J Thorac Oncol 2016 06 1;11(6):789-800. Epub 2016 Feb 1.

Institute of Clinical Medicine, The Arctic University of Norway, Tromsø, Norway; Department of Oncology, University Hospital of Northern Norway, Tromsø, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.01.015DOI Listing
June 2016

Alterations of MET Gene Copy Number and Protein Expression in Primary Non-Small-Cell Lung Cancer and Corresponding Nodal Metastases.

Clin Lung Cancer 2016 Jan 18;17(1):30-8.e1. Epub 2015 Aug 18.

Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; School of Medicine, University of Western Sydney, New South Wales, Australia; Sydney Medical School, University of Sydney, New South Wales, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2015.08.002DOI Listing
January 2016

PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma.

Lung Cancer 2015 Aug 18;89(2):181-8. Epub 2015 May 18.

Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.05.007DOI Listing
August 2015

BRAF mutations in non-small cell lung cancer.

Transl Lung Cancer Res 2015 Apr;4(2):142-8

1 Department of Tissue Pathology and Diagnostic Oncology, 2 Department of Medical Genomics, Royal Prince Alfred Hospital, Sydney, Australia ; 3 Sydney Medical School, University of Sydney, Sydney, Australia ; 4 Lifehouse Cancer Centre, The Chris O'Brien Lifehouse, Sydney, Australia ; 5 Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia ; 6 School of Medicine, University of Western Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2014.08.08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384219PMC
April 2015

The suitability of small biopsy and cytology specimens for EGFR and other mutation testing in non-small cell lung cancer.

Transl Lung Cancer Res 2015 Apr;4(2):119-25

1 Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia ; 2 Sydney Medical School, The University of Sydney, NSW 2006, Australia ; 3 Medical Genomics, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia ; 4 The Kinghorn Cancer Centre and Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia ; 5 School of Medicine, University of Western Sydney, Campbelltown, NSW 2560, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2015.01.05DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384210PMC
April 2015

Preface-molecular genetics of lung cancer.

Authors:
Wendy A Cooper

Transl Lung Cancer Res 2015 Apr;4(2):109

Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2015.02.01DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384211PMC
April 2015

Response to Mahe.

Mod Pathol 2014 Oct;27(10):1424-5

1] Peter MacCallum Cancer Centre, Department of Medical Oncology, East Melbourne, VIC, Australia [2] University of Melbourne, Parkville, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2014.58DOI Listing
October 2014

EGFR mutation specific immunohistochemistry is a useful adjunct which helps to identify false negative mutation testing in lung cancer.

Pathology 2014 Oct;46(6):501-8

1Cancer Diagnosis and Pathology Group, Northern Translational Cancer Research Unit, Kolling Institute of Medical Research, St Leonards 2Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards 3Sydney Medical School, University of Sydney, Sydney 4HistoPath Pathology, North Ryde 5Tissue Oncology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown 6School of Medicine, University of Western Sydney, Sydney 7Department of Medical Oncology, Royal North Shore Hospital, St Leonards 8Kinghorn Cancer Centre and Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst 9University of NSW, Sydney 10Department of Anatomical Pathology, SydPath, St Vincent's Hospital, Darlinghurst, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAT.0000000000000141DOI Listing
October 2014

Reflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancer.

Pathology 2014 Aug;46(5):383-8

1Cancer Diagnosis and Pathology Group, Northern Translational Cancer Research Unit, Kolling Institute of Medical Research, St Leonards 2Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards 3Sydney Medical School, University of Sydney, Sydney 4HistoPath Pathology, North Ryde 5Department of Tissue Oncology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown 6Department of Anatomical Pathology, SydPath, St Vincent's Hospital, Darlinghurst 7School of Medicine, University of Western Sydney 8Kinghorn Cancer Centre and Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAT.0000000000000114DOI Listing
August 2014

Molecular biology of lung cancer.

J Thorac Dis 2013 Oct;5 Suppl 5:S479-90

Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Sydney, NSW, Australia; ; School of Medicine, University of Western Sydney, NSW, Australia;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2072-1439.2013.08.03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804875PMC
October 2013

Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer.

Lung Cancer 2013 Sep 24;81(3):462-467. Epub 2013 Jun 24.

Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; School of Medicine, University of Western Sydney, New South Wales, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.05.015DOI Listing
September 2013

Patterns of DNA mutations and ALK rearrangement in resected node negative lung adenocarcinoma.

J Thorac Oncol 2013 Apr;8(4):408-14

Department of Medical Oncology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318283558eDOI Listing
April 2013

Loss of heterozygosity of the Mutated in Colorectal Cancer gene is not associated with promoter methylation in non-small cell lung cancer.

Lung Cancer 2012 Aug 26;77(2):272-6. Epub 2012 Apr 26.

Department of Molecular and Clinical Genetics, Royal Prince Alfred Hospital, Missenden Road, Camperdown, Sydney, NSW 2050, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2012.04.001DOI Listing
August 2012

What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements.

Pathology 2011 Feb;43(2):103-15

Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAT.0b013e328342629dDOI Listing
February 2011

Lymphoma occurring in patients with cutaneous melanoma.

J Clin Pathol 2010 Sep 29;63(9):777-81. Epub 2010 Jul 29.

Erasmus MC, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jcp.2010.077768DOI Listing
September 2010

Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer.

Histopathology 2009 Jul;55(1):28-36

Department of Anatomical Pathology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2559.2009.03331.xDOI Listing
July 2009

Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma.

Histopathology 2009 Mar;54(4):462-70

Department of Anatomical Pathology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2559.2009.03242.xDOI Listing
March 2009

PEComa of the retroperitoneum.

Pathology 2008 Jan;40(1):93-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00313020701716300DOI Listing
January 2008

Asbestos exposure and lung cancer.

Pathology 2004 Dec;36(6):513-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00313020400012050DOI Listing
December 2004

An unusual pleural spindle cell tumour. Part 1.

Pathology 2002 Aug;34(4):370-4

Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/003130202760120562DOI Listing
August 2002

Nuclear magnetic resonance-visible lipids induced by cationic lipophilic chemotherapeutic agents are accompanied by increased lipid droplet formation and damaged mitochondria.

Cancer Res 2002 Mar;62(5):1394-400

Department of Cancer Medicine, The University of Sydney, New South Wales 2006, Australia.

View Article

Download full-text PDF

Source
March 2002